Targeted agents in triple negative breast cancer (Homo sapiens)

From WikiPathways

Revision as of 23:47, 12 June 2024 by Khanspers (Talk | contribs)
Jump to: navigation, search
ArcPathVisio Brace Ellipse EndoplasmicReticulum GolgiApparatus HexagonPathVisio MimDegradation Mitochondria Octagon PentagonPathVisio Rectangle RoundedRectangle SarcoplasmicReticulum TriangleEquilateralEast TrianglePathVisio none IRS1PDK1RPS6KB1MK2206PIP2dactolisibalpelisibPI3kINPP4BAKT1mTORC1PTENEIF4EBP1MTOReverolimustemsirolimusTSC1TSC2buparlisibpictilisibPI3kmTORC2PIP3Name: Relevant molecular pathways and targeted agents in TNBCOrganism: Homo sapiens


Description

Schematic of the most relevant molecular pathways and targeted agents in TNBC. Tyrosine kinase receptor is activated upon binding of growth factors leading to activation of signaling pathways. PI3K/AKT pathway and inhibitor drugs: Phosphorylated PI3K activate AKT. The activation of AKT triggers downstream protein complexes mTORC activation that initiate gene transcription and promote cell growth. AR pathway is activated in LAR subtype tumors. Platinum drugs act through DNA damaging mechanism. PARP inhibitors induce “synthetic lethality” in BRCA deficient tumors.

Try the New WikiPathways

View approved pathways at the new wikipathways.org.

Quality Tags

Ontology Terms

Pathway Ontology : regulatory pathway
 

Bibliography

  1. Vagia E, Mahalingam D, Cristofanilli M; ''The Landscape of Targeted Therapies in TNBC.''; Cancers (Basel), 2020 PubMed Europe PMC Scholia

History

View all...
CompareRevisionActionTimeUserComment
137704view11:26, 7 March 2025EweitzAlign interactions, refine layering
137703view11:24, 7 March 2025EweitzEconomize layout
137702view11:19, 7 March 2025EweitzEconomize layout
137701view11:13, 7 March 2025EweitzStandardize case
137657view12:16, 6 March 2025EweitzStack nodes
137656view12:14, 6 March 2025EweitzTailor node width
137655view12:08, 6 March 2025EweitzTailor node height
137631view21:49, 5 March 2025KhanspersModified description
135833view13:42, 15 November 2024EweitzOntology Term : 'breast cancer pathway' added !
135832view13:36, 15 November 2024EweitzModified title
135288view18:02, 14 August 2024Khansperslayout, xrefs
134125view01:07, 29 June 2024Khanspersadded mapk signaling arm, cell and nucleus, mTORC complexes
134025view23:49, 12 June 2024KhanspersModified description
134024view23:47, 12 June 2024KhanspersModified title
134023view23:47, 12 June 2024Khansperscleanup: added xrefs, improve layout
134020view23:30, 12 June 2024KhanspersOntology Term : 'altered signaling pathway' added !
134019view23:29, 12 June 2024KhanspersOntology Term : 'triple-receptor negative breast cancer' added !
122330view12:36, 18 March 2022AndraNew pathway

External references

DataNodes

View all...
Name  ↓Type  ↓Database reference  ↓Comment  ↓
AKT1GeneProduct207 (Entrez Gene)
EIF4EBP1GeneProductEIF4EBP1 (HGNC)
INPP4BGeneProduct8821 (Entrez Gene)
IRS1GeneProduct3667 (Entrez Gene)
MK2206Metabolite
MTORGeneProduct2475 (Entrez Gene)
PDK1GeneProduct5163 (Entrez Gene)
PI3kGeneProduct
PIP2MetaboliteQ3083814 (Wikidata)
PIP3MetaboliteQ3078767 (Wikidata)
PTENGeneProduct5728 (Entrez Gene)
RPS6KB1GeneProductRPS6KB1 (HGNC)
TSC1GeneProductTSC1 (HGNC)
TSC2GeneProductTSC2 (HGNC)
alpelisibMetaboliteQ27074391 (Wikidata)
buparlisibMetaboliteQ25100534 (Wikidata)
dactolisibMetaboliteQ4835503 (Wikidata)
everolimusMetaboliteQ421052 (Wikidata)
mTORC1GeneProduct
mTORC2GeneProduct
pictilisibMetaboliteQ27088388 (Wikidata)
temsirolimusMetaboliteQ7699074 (Wikidata)

Annotated Interactions

No annotated interactions

Retrieved from "https://classic.wikipathways.org/index.php/Pathway:WP5215"
Personal tools